TYTevfik Yilmaz

Tevfik Yilmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tevfik Yilmaz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dose-dependent protective profile of trans-anethole in experimental traumatic brain injury in mice via modulation of apoptotic and inflammatory protein expression, and oxidative stress

    by Aziz Çevik, Burak Atlas, Gamze Erdoğan, Mehmet Salih Atama, Barış Altun, Tevfik Yılmaz

    Purpose: To investigate the protective effect of trans-anethole in experimental traumatic brain injury (TBI) in mice. Methods: Thirty-five adult mice were divided into five groups (control, TBI, TBI+A40, TBI+A80, and TBI+A160). No treatment was performed in the control group. The treated groups (TBI+A40, TBI+A80, and TBI+A160) received 40, 80 or 160 mg/kg trans-anethole treatment, respectively. At the end of the experiment, the brains of the sacrificed animals were removed, and laboratory analyses were performed. Results: Malondialdehyde (MDA) levels in brain tissue of TBI and TBI+A40 were significantly increased, while MDA levels of TBI+A80 and TBI were similar. TBI+A160 and control tissue MDA levels were similar (p > 0.05), significantly different from TBI (p < 0.01). Immunodensity analyses showed that there was a significant difference between the control and TBI in terms of Bax, caspase 3, tumor necrosis factor-α (TNF-α) and interleukin- (IL)-1β immunoexpression. TBI+A40 immunoexpression was similar to TBI (p > 0.05), significantly different from the control groups (p < 0.05). In TBI+A80 and TBI+A160, pro-apoptotic Bax and caspase 3, pro-inflammatory TNF-α and IL-1β levels were also significantly improved. Immunoexpression levels of TBI+A160 and control were similar (p > 0.05). Conclusion: in our study, trans-anethole treatment had a dose-dependent neuroprotective potential against trauma-induced neurodegeneration.

  • Analysis of 55 Adult Cases Surgically Treated for Pontocerebellar Angle Tumors

    by İbtahim Başar, Sinan Bahadir, Murat Yücel, Tevfik Yilmaz

    Objective: Pontocerebellar angle (PCA) tumors, although typically of benign nature, are of significant clinical and pathological importance. The aim of this study is to investigate the clinical and pathological characteristics of PCA tumors, as well as surgical outcomes, which hold a significant place in clinical practice. Methods: 55 adult patients who underwent surgery for PCA tumors at the Department of Neurosurgery, Dicle University Faculty of Medicine, between 2013 and 2023 were included in the study. The clinical and pathological records of these patients were retrospectively reviewed. Results: The age of the patients (17 male, 38 female) ranged from 18 to 75 years. According to pathological diagnosis, 23 cases were diagnosed as meningioma, 19 as schwannoma, 6 as epidermoid tumors, 2 as metastases, 1 as hemangioblastoma, 1 as hemangioma, 1 as medulloblastoma, 1 as neuroblastoma, and 1 as small round cell tumor. Gross total resection was achieved in all cases. Overall, 47.3% of the patients had one or more postoperative complications. Postoperative permanent facial palsy developed in 6 patients. The overall mortality rate was 9%. Conclusion: Pontocerebellar angle tumors constitute a significant group among intracranial tumors. Surgical treatment is an important option for the management of these tumors. Primary goal of the surgery is gross total resection which is feasible in today. Though postoperative complications are common, majority of them is temporary.

  • Open Access

    İntrakranial Menenjioma Olgularının Değerlendirilmesi: 72 Hastanın Analizi

    by Yahya Turan, Tevfik Yilmaz

    Amaç: Kliniğimizde 2012–2018 yıllarında ameliyat olmuş ve menenjiom tanısı almış olan 72 hasta retrospektif olarak klinik, radyolojik ve patolojik bulgularıyla incelenerek literatür eşliğinde tartışıldı. Yöntemler: Hastaların yaşları, cinsiyetleri, klinik bulguları, radyolojik görüntüleri, yerleşim yerleri, ameliyat kayıtları ve patolojik olarak aldıkları tanıları incelendi.Bulgular: 72 intrakranial menenjiomalı hastanın 47 (%65,3)’i kadın, 25 (%34,7)’i erkektir. Kadın/Erkek oranı: 1.88’dir. Olgular 19-78 yaş aralığında olup, yaş ortalaması 44.7’dir. Sıklık sırasına göre başvurma nedenleri ve nörolojik muayene bulguları: Baş ağrısı (%72,2), bulantı-kusma (%37,5), epilepsi (%25,0), motor defisit (%20,8)’dir. En sık yerleştikleri lokalizasyonlar: konvexite 17 (%23,7), parasagital 14 (%19,5), sfenoid kanat 9 (%12,59 bölgesidir. Cerrahi tedavideki rezeksiyonumuzun Simpson klasifikasyonuna göre; hastaların 57 (%79,2)’i grade I, 8 (%11,1)’i grade II, 2 (%2,8)’i grade III, 4 (%5,5)’i grade IV ve 1 (%1,4)’i grade V olarak değerlendirilmiştir. Histopatojik tanıları ise sıklık sırasına göre; 29 (%40,3) meningotelyomatöz, 13 (%18,1) fibröz, 9 (%12,5) transisyonel, 6 (%8,3) oranında psammomatöz tip şeklinde tespit edildi.Sonuç: İntrakranial menenjiomalar malign tipleri dışında; genellikle benign karekterde yavaş büyüyen, erken tanı konup, total çıkarıldığında tam kür sağlanan, rekürrens oranı çok düşük olan tümörlerdir. Menenjiomalarda cerrahi kararın verilmesinde ve sürvide; hastaların yaşı, preoperatif performans skalası, tümörün lokalizasyonu, büyüklüğü, rezeksiyon derecesi, histopatolojik özellikleri gibi birçok faktör rol oynamaktadır. Asemptomatik, küçük boyutta, ameliyata uygun olmayan, yaşlı, kafa tabanı, kavernöz sinüs gibi ulaşılması zor lokalizasyonlarda bulunan hastalarda seri görüntülemelerle yakın takip ve radyocerrahi tercih edilebilir. MRG takibi 3. ay, 6. ay ve sonrasında yıllık takipler şeklinde ve takipte gerek görülürse, büyüme olursa cerrahi/radyocerrahi önerilir. Genç olan ve kalsifikasyonu bulunmayanlarda hızlı büyüme riski nedeniyle cerrahi düşünülmelidir.